Clinical Trial Analysis
Insights for "A"
Overview
Total Trials
82,091
All registered studies
Active Recruiting
23,011
28.0%
Currently enrolling patients
Completed
57,787
70.4%
Studies finished
Phase 3 Studies
14.0%
Advanced phase trials
Key Insights
Leading Region
USA
Most active geographical area
Top Organization
Hoffmann-La Roche
Most active research sponsor
Distribution Analysis
Study Phases
Trial distribution by development phase
Not Applicable
30,33337.0%
Phase 1
19,09223.3%
Phase 2
14,93218.2%
Phase 3
11,47914.0%
Phase 4
5,3786.6%
Early Phase 1
8771.1%
Not Applicable
30,33337.0%
Phase 1
19,09223.3%
Phase 2
14,93218.2%
Phase 3
11,47914.0%
Phase 4
5,3786.6%
Early Phase 1
8771.1%
Recruitment Status
Current enrollment and completion status
Total: 99,798
Geographic & Sponsor Analysis
Geographic Distribution
Trial activity by country
Top Sponsors
Most active research organizations
Rank
Company
Count
1
Hoffmann-La Roche
1622
2
Pfizer
1560
3
Eli Lilly and Company
1429
4
Novo Nordisk A/S
1301
5
GlaxoSmithKline
1201
6
AstraZeneca
928
7
Merck Sharp & Dohme LLC
895
8
Janssen Research & Development, LLC
725
9
National Institute of Allergy and Infectious Diseases (NIAID)
716
10
Bristol-Myers Squibb
701
Medical Focus Areas
Medical Conditions
Most studied disease areas
Rank
Condition
Count
1
Healthy
3117
2
Breast Cancer
1490
3
Obesity
1255
4
HIV Infections
1199
5
Diabetes Mellitus, Type 2
1161
6
Healthy Volunteers
1069
7
Diabetes
969
8
Cancer
769
9
Asthma
710
10
Rheumatoid Arthritis
693
Treatment Types
Most common interventions
Rank
Intervention
Count
1
Placebo
9730
2
Carboplatin
445
3
Pembrolizumab
443
4
Paclitaxel
405
5
Cyclophosphamide
372
6
Cisplatin
346
7
Gemcitabine
332
8
Dexamethasone
306
9
Bevacizumab
293
10
Rituximab
284